| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc788dc22d2fff9e51fb63ddf3976055 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-431 |
| filingDate |
2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7a8559703a93484d836651ce728e2da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22083d7db7bb29e1b8f7bbd7cc5e2e14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8b828d7bdb808cfbd999fb267f41567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05e95ebb46556b4fa958732cf2f54a59 |
| publicationDate |
2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2016017182-A |
| titleOfInvention |
USE OF SODIUM PIPERACILINE FOR THE TREATMENT OF CHAGAS DISEASE AS AN ANTI-TRYPANOSOMA CRUZI AGENT. |
| abstract |
This invention refers to the use of sodium piperacillin with excellent selectivity over Trypanosoma cruzi. The present invention comprises sodium piperacillin, as well as its pharmaceutically acceptable salts and its use in medicaments for treating human and mammalian animals with Chagas disease or American trypanosomiasis. |
| priorityDate |
2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |